More on ARTV

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Artiva Biotherapeutics (NQ:ARTV)
Delayed: 10.42 -0.37 (3.43%)
Prev. Close $10.79  
Open$10.70 
52 Wk High$ 
52 Wk Low$ 
Day High$10.93 
Day Low$10.36 
P/E N/A  
EPS$ 
Volume449,477 

Friends, Peers and Foes (?): CTNM (more...)

Sep 8, 2026 07:30 AM Artiva plans Phase 3 trial and data updates for AlloNK in 2026
Sep 8, 2026 07:30 AM Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026
Sep 2, 2026 08:30 AM Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
Aug 27, 2026 04:20 PM Form 144 Artiva Biotherapeutics, Filed by: Banerjee Subhashis
Aug 19, 2026 09:01 PM Form 4 Artiva Biotherapeutics, For: Aug 18 Filed by: Banerjee Subhashis
Aug 18, 2026 04:31 PM Form 144 Artiva Biotherapeutics, Filed by: Banerjee Subhashis
Aug 17, 2026 06:15 AM Form EFFECT Artiva Biotherapeutics,
Aug 14, 2026 04:51 PM Form SCHEDULE 13G/A Artiva Biotherapeutics, Filed by: Venrock Healthcare Capital Partners III, L.P.
Aug 10, 2026 07:50 PM Form SCHEDULE 13G/A Artiva Biotherapeutics, Filed by: 5AM Ventures VI, L.P.
Aug 7, 2026 04:23 PM Artiva Biotherapeutics, Inc. (ARTV) Misses Q2 EPS by 63c
View All Articles

Entities mentioned with ARTV

View All Entities